» Articles » PMID: 20174577

THC Prevents MDMA Neurotoxicity in Mice

Overview
Journal PLoS One
Date 2010 Feb 23
PMID 20174577
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The majority of MDMA (ecstasy) recreational users also consume cannabis. Despite the rewarding effects that both drugs have, they induce several opposite pharmacological responses. MDMA causes hyperthermia, oxidative stress and neuronal damage, especially at warm ambient temperature. However, THC, the main psychoactive compound of cannabis, produces hypothermic, anti-inflammatory and antioxidant effects. Therefore, THC may have a neuroprotective effect against MDMA-induced neurotoxicity. Mice receiving a neurotoxic regimen of MDMA (20 mg/kg x 4) were pretreated with THC (3 mg/kg x 4) at room (21 degrees C) and at warm (26 degrees C) temperature, and body temperature, striatal glial activation and DA terminal loss were assessed. To find out the mechanisms by which THC may prevent MDMA hyperthermia and neurotoxicity, the same procedure was carried out in animals pretreated with the CB(1) receptor antagonist AM251 and the CB(2) receptor antagonist AM630, as well as in CB(1), CB(2) and CB(1)/CB(2) deficient mice. THC prevented MDMA-induced-hyperthermia and glial activation in animals housed at both room and warm temperature. Surprisingly, MDMA-induced DA terminal loss was only observed in animals housed at warm but not at room temperature, and this neurotoxic effect was reversed by THC administration. However, THC did not prevent MDMA-induced hyperthermia, glial activation, and DA terminal loss in animals treated with the CB(1) receptor antagonist AM251, neither in CB(1) and CB(1)/CB(2) knockout mice. On the other hand, THC prevented MDMA-induced hyperthermia and DA terminal loss, but only partially suppressed glial activation in animals treated with the CB(2) cannabinoid antagonist and in CB(2) knockout animals. Our results indicate that THC protects against MDMA neurotoxicity, and suggest that these neuroprotective actions are primarily mediated by the reduction of hyperthermia through the activation of CB(1) receptor, although CB(2) receptors may also contribute to attenuate neuroinflammation in this process.

Citing Articles

Interplay Between Astroglial Endocannabinoid System and the Cognitive Dysfunction in Alzheimer's Disease.

Rapaka D, Adiukwu P, Challa S, Bitra V Physiol Res. 2023; 72(5):575-586.

PMID: 38015757 PMC: 10751057. DOI: 10.33549/physiolres.935156.


Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences.

Costa G, Caputi F, Serra M, Simola N, Rullo L, Stamatakos S Front Pharmacol. 2021; 12:713486.

PMID: 34512343 PMC: 8430399. DOI: 10.3389/fphar.2021.713486.


Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities.

Elliott L, Haddock C, Campos S, Benoit E PLoS One. 2019; 14(12):e0225273.

PMID: 31794586 PMC: 6890248. DOI: 10.1371/journal.pone.0225273.


Cannabinoid 1 Receptor Signaling on Hippocampal GABAergic Neurons Influences Microglial Activity.

Ativie F, Komorowska J, Beins E, Albayram O, Zimmer T, Zimmer A Front Mol Neurosci. 2018; 11:295.

PMID: 30210289 PMC: 6121063. DOI: 10.3389/fnmol.2018.00295.


Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.

Porceddu P, Ishola I, Contu L, Morelli M Neurotox Res. 2016; 30(1):101-9.

PMID: 27251371 DOI: 10.1007/s12640-016-9633-5.


References
1.
OCallaghan J, Miller D . Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther. 1994; 270(2):741-51. View

2.
Rawls S, Cabassa J, Geller E, Adler M . CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. J Pharmacol Exp Ther. 2002; 301(3):963-8. DOI: 10.1124/jpet.301.3.963. View

3.
Jarai Z, Wagner J, Varga K, Lake K, Compton D, Martin B . Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A. 1999; 96(24):14136-41. PMC: 24203. DOI: 10.1073/pnas.96.24.14136. View

4.
Chen Y, Buck J . Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J Pharmacol Exp Ther. 2000; 293(3):807-12. View

5.
OShea E, Orio L, Escobedo I, Sanchez V, Camarero J, Green A . MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature. Br J Pharmacol. 2006; 148(6):778-85. PMC: 1617070. DOI: 10.1038/sj.bjp.0706783. View